Patents by Inventor Peter Sjo

Peter Sjo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel 5,6-Dihydropyrazolo[3,4-E] [L,4]Diazepin-4 (IH) -One Derivatives for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease
    Publication number: 20090054413
    Abstract: The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a PDE 4 mediated disease state.
    Type: Application
    Filed: October 2, 2006
    Publication date: February 26, 2009
    Applicant: AstraZeneca AB
    Inventors: Krister Henriksson, Annea Lisius, Peter Sjo, Peter Storm
  • Pyridopyrimidine Derivatives as Pde4 Inhibitors for the Treatment of Inflammatory and Immune Diseases
    Publication number: 20080227797
    Abstract: The present invention provides a compound of a formula (I): [Chemical formula should be inserted here. Please see paper copy] wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a PDE4 mediated disease state.
    Type: Application
    Filed: July 3, 2006
    Publication date: September 18, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Annea Lisius, Grigorios Nikitidis, Peter Sjo
  • Novel 4-anilinoquinoline-3-carboxamides
    Publication number: 20060173034
    Abstract: The present invention relates to novel compounds which are JAK3 Kinase inhibitors, methods for their preparation intermediates and pharmaceutical compositions comprising them.
    Type: Application
    Filed: March 6, 2006
    Publication date: August 3, 2006
    Applicant: AstraZeneca AB
    Inventors: Joakim Larsson, Peter Sjo
  • Novel use of benzothiazole derivatives
    Publication number: 20060106015
    Abstract: The use of compounds of formula (I) wherein X, A, B, D, R1 and R2 are as defined in the Specification and pharmaceutically acceptable salts thereof in the manufacture of a medicament for the treatment or prophylaxis of diseases or conditions in which inhibition of kinase Itk activity is beneficial is disclosed. Certain novel compounds of formula (I), together with processes for their preparation, compositions containing them and their use in therapy are also disclosed.
    Type: Application
    Filed: August 13, 2003
    Publication date: May 18, 2006
    Inventors: Peter Sjo, Peter Storm
  • Use of and some novel imidazopyridines
    Publication number: 20050261333
    Abstract: The use of compounds of formula (I) wherein R1, R3, R10, m and Ar are as defined in the Specification and pharmaceutically acceptable salts thereof in the manufacture of a medicament for the treatment or prophylaxis of diseases or conditions in which inhibition of kinase Itk activity is beneficial is disclosed. Certain novel compounds of formula (I), together with processes for their preparation, compositions containing them and their use in therapy are also disclosed.
    Type: Application
    Filed: August 13, 2003
    Publication date: November 24, 2005
    Applicant: AstraZeneca A B
    Inventors: Henrik Johansson, Karolina Lawitz, Grigorios Nikitidis, Peter Sjo, Peter Storm
  • Substituted pyrrolopyridines
    Publication number: 20050261331
    Abstract: There are provided novel compounds of formula (I) wherein R1, R2 and R3 are as defined in the specification and pharmaceutically acceptable salts thereof; together with processes for their preparation, compositions containing them and their use in therapy. The compounds are inhibitors of the kinase Itk.
    Type: Application
    Filed: August 13, 2003
    Publication date: November 24, 2005
    Inventors: Peter Nielsen, Thomas Brimert, Anna Kristofferson, Tero Linnanen, Peter Sjo
  • Substituted pyrrolopyridines
    Publication number: 20050215582
    Abstract: There are provided novel compounds of formula (I) wherein R1, R2 and R3 are as defined in the specification and pharmaceutically acceptable salts thereof; together with processes for their preparation, compositions containing them and their use in therapy. The compounds are inhibitors of the kinase Itk.
    Type: Application
    Filed: August 13, 2003
    Publication date: September 29, 2005
    Inventors: Peter Nielsen, Thomas Brimert, Anna Kristoffersson, Tero Linnanen, Peter Sjo
  • Novel 4-anilinoquinoline-3-carboxamides
    Publication number: 20040248923
    Abstract: The present invention relates to novel compounds of formula (IA), which are JAK3 Kinase inhibitors, methods for their preparation and pharmaceutical compositions comprising them.
    Type: Application
    Filed: November 10, 2003
    Publication date: December 9, 2004
    Inventors: Joakim Larsson, Peter Sjo
  • Pharmaceutically active compounds
    Publication number: 20030134886
    Abstract: The present invention relates to compounds of formula (I) 1
    Type: Application
    Filed: November 6, 2002
    Publication date: July 17, 2003
    Applicant: ASTRAZENECA AB, a Swedish Corporation
    Inventors: Kostas Karabelas, Matti Lepisto, Peter Sjo
  • New pharmaceutical active compounds
    Publication number: 20010025043
    Abstract: The present invention provides optionally substituted and/or annulated compounds of formula (I) 1
    Type: Application
    Filed: May 25, 2001
    Publication date: September 27, 2001
    Applicant: Astra Aktiebolag, a Sweden corporation
    Inventors: Hakan Bergstrand, Kostas Karabelas, Peter Sjo